We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
SLSN's Earnings Break-Even in Q2, High Operating Costs Hurt
Read MoreHide Full Article
Shares of Solesence, Inc. (SLSN - Free Report) have gained 6.5% since the company reported its earnings for the quarter ended June 30, 2026. This compares with the S&P 500 index’s 0.2% decline over the same time frame. Over the past month, the stock has gained 1.5% compared with the S&P 500’s 3.7% increase.
Solesence reported second-quarter 2026 breakeven earnings per share, compared with earnings of 4 cents per share in the prior-year period.
Revenues of $15.3 million denoted a 25% decline from $20.4 million in the year-ago quarter. The prior-year period benefited from a one-time revenue boost associated with a major Solesence product launch and initial inventory pipeline fill. The company posted a net loss of $0.2 million against a net income of $3.2 million a year earlier. Gross profit declined about 26% to $4.7 million from $6.4 million.
Gross margin was 31% in the second quarter compared with 32% a year earlier. Adjusted EBITDA declined to $0.5 million from $3.7 million in the prior-year quarter. Research and development expenses were relatively stable at $1 million, while selling, general and administrative expenses increased about 22% to $3.7 million from $3 million. Interest expense rose to $0.3 million from $0.1 million.
At June 30, 2026, Solesence had cash of roughly $1 million, down from $1.3 million at Dec. 31, 2025. Total assets remained nearly unchanged at $46.4 million.
Net trade accounts receivable increased to $9.3 million from $6.8 million, while inventories declined to $13 million from $15 million.
Meanwhile, total stockholders’ equity declined to $13.2 million from $14.1 million at 2025-end.
Management Commentary
Management said the company remained focused on operational execution and financial discipline under its Transform and Transcend strategy. Solesence is leveraging its intellectual property to enter high-growth markets, expanding co-marketing initiatives and pursuing targeted operational efficiencies.
Management highlighted progress in production efficiency, citing improvements in labor efficiency and lower production and manufacturing costs. The company has implemented Kaizen initiatives aimed at identifying inefficiencies and improving processes. Management also discussed expansion into scalp-care products, including shampoo and SPF offerings, as another avenue for growth.
Factors Influencing Headline Numbers
The year-over-year revenue decline largely reflected a difficult comparison with the second quarter of 2025, when results benefited from a major product launch and initial inventory pipeline fill. Management said revenues from that product were lower in the latest quarter because the 2025 launch resulted in initial orders and forecasts for the product line. Growth from other brand partners in the prestige beauty sector partially offset the decline.
Profitability was also affected by the lower revenue base, higher SG&A expenses and increased interest expense. However, management pointed to continued improvements in labor efficiency as supportive of gross profit performance.
Guidance
Management expects third-quarter revenues and profitability to improve sequentially and projects the second half of 2026 to generate approximately $35 million in revenues, which it described as potentially the strongest second-half performance in the company’s history. As of Aug. 17, shipped and on-hand orders expected to ship in 2026 totaled $64.9 million, up from $60 million in the comparable prior-year period. Management also said it expects full-year revenues to exceed 2025 levels.
Image: Bigstock
SLSN's Earnings Break-Even in Q2, High Operating Costs Hurt
Shares of Solesence, Inc. (SLSN - Free Report) have gained 6.5% since the company reported its earnings for the quarter ended June 30, 2026. This compares with the S&P 500 index’s 0.2% decline over the same time frame. Over the past month, the stock has gained 1.5% compared with the S&P 500’s 3.7% increase.
Solesence reported second-quarter 2026 breakeven earnings per share, compared with earnings of 4 cents per share in the prior-year period.
Revenues of $15.3 million denoted a 25% decline from $20.4 million in the year-ago quarter. The prior-year period benefited from a one-time revenue boost associated with a major Solesence product launch and initial inventory pipeline fill. The company posted a net loss of $0.2 million against a net income of $3.2 million a year earlier. Gross profit declined about 26% to $4.7 million from $6.4 million.
Solesence, Inc. Price, Consensus and EPS Surprise
Solesence, Inc. price-consensus-eps-surprise-chart | Solesence, Inc. Quote
Other Key Business Metrics
Gross margin was 31% in the second quarter compared with 32% a year earlier. Adjusted EBITDA declined to $0.5 million from $3.7 million in the prior-year quarter. Research and development expenses were relatively stable at $1 million, while selling, general and administrative expenses increased about 22% to $3.7 million from $3 million. Interest expense rose to $0.3 million from $0.1 million.
At June 30, 2026, Solesence had cash of roughly $1 million, down from $1.3 million at Dec. 31, 2025. Total assets remained nearly unchanged at $46.4 million.
Net trade accounts receivable increased to $9.3 million from $6.8 million, while inventories declined to $13 million from $15 million.
Meanwhile, total stockholders’ equity declined to $13.2 million from $14.1 million at 2025-end.
Management Commentary
Management said the company remained focused on operational execution and financial discipline under its Transform and Transcend strategy. Solesence is leveraging its intellectual property to enter high-growth markets, expanding co-marketing initiatives and pursuing targeted operational efficiencies.
Management highlighted progress in production efficiency, citing improvements in labor efficiency and lower production and manufacturing costs. The company has implemented Kaizen initiatives aimed at identifying inefficiencies and improving processes. Management also discussed expansion into scalp-care products, including shampoo and SPF offerings, as another avenue for growth.
Factors Influencing Headline Numbers
The year-over-year revenue decline largely reflected a difficult comparison with the second quarter of 2025, when results benefited from a major product launch and initial inventory pipeline fill. Management said revenues from that product were lower in the latest quarter because the 2025 launch resulted in initial orders and forecasts for the product line. Growth from other brand partners in the prestige beauty sector partially offset the decline.
Profitability was also affected by the lower revenue base, higher SG&A expenses and increased interest expense. However, management pointed to continued improvements in labor efficiency as supportive of gross profit performance.
Guidance
Management expects third-quarter revenues and profitability to improve sequentially and projects the second half of 2026 to generate approximately $35 million in revenues, which it described as potentially the strongest second-half performance in the company’s history. As of Aug. 17, shipped and on-hand orders expected to ship in 2026 totaled $64.9 million, up from $60 million in the comparable prior-year period. Management also said it expects full-year revenues to exceed 2025 levels.